| scholarly article | Q13442814 |
| P50 | author | Martin R. Turner | Q39982364 |
| P2093 | author name string | M C Evans | |
| N Sibson | |||
| Y Couch | |||
| P921 | main subject | amyotrophic lateral sclerosis | Q206901 |
| P304 | page(s) | 34-41 | |
| P577 | publication date | 2012-10-27 | |
| P1433 | published in | Molecular and Cellular Neuroscience | Q6895985 |
| P1476 | title | Inflammation and neurovascular changes in amyotrophic lateral sclerosis | |
| P478 | volume | 53 |
| Q36326816 | A Perspective on Roles Played by Innate and Adaptive Immunity in the Pathobiology of Neurodegenerative Disorders |
| Q37337058 | A(a)LS: Ammonia-induced amyotrophic lateral sclerosis |
| Q41893910 | APOE genotype-dependent modulation of astrocyte chemokine CCL3 production. |
| Q35605786 | Absence of toll-like receptor 4 (TLR4) extends survival in the hSOD1 G93A mouse model of amyotrophic lateral sclerosis |
| Q28389801 | Acute Traumatic Brain Injury Does Not Exacerbate Amyotrophic Lateral Sclerosis in the SOD1 (G93A) Rat Model(1,2,3) |
| Q33563621 | Amyotrophic lateral sclerosis, gene deregulation in the anterior horn of the spinal cord and frontal cortex area 8: implications in frontotemporal lobar degeneration |
| Q42772755 | Anti-inflammatory therapies of amyotrophic lateral sclerosis guided by immune pathways |
| Q36909735 | Bid Promotes K63-Linked Polyubiquitination of Tumor Necrosis Factor Receptor Associated Factor 6 (TRAF6) and Sensitizes to Mutant SOD1-Induced Proinflammatory Signaling in Microglia. |
| Q59328934 | Blood Level of Glial Fibrillary Acidic Protein (GFAP) Does not Correlate With Disease Progression in a Rat Model of Familial ALS (SOD1 Transgenic) |
| Q27026792 | Blood-CNS Barrier Impairment in ALS patients versus an animal model |
| Q34500059 | CNS-targeted glucocorticoid reduces pathology in mouse model of amyotrophic lateral sclerosis |
| Q36898459 | CSF1R blockade slows the progression of amyotrophic lateral sclerosis by reducing microgliosis and invasion of macrophages into peripheral nerves |
| Q21132045 | CX3CR1 is a modifying gene of survival and progression in amyotrophic lateral sclerosis |
| Q40642266 | Cardiovascular disease and diagnosis of amyotrophic lateral sclerosis: A population based study |
| Q88374497 | Carotenoids and Neurobiological Health |
| Q47587631 | Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry |
| Q33895668 | Cerebrospinal fluid levels of inflammation, oxidative stress and NAD+ are linked to differences in plasma carotenoid concentrations. |
| Q37164902 | Cerebrospinal fluid of newly diagnosed amyotrophic lateral sclerosis patients exhibits abnormal levels of selenium species including elevated selenite. |
| Q35129108 | Chemokine CXCL8 promotes HIV-1 replication in human monocyte-derived macrophages and primary microglia via nuclear factor-κB pathway. |
| Q64118808 | Circulating Cytokines Could Not Be Good Prognostic Biomarkers in a Mouse Model of Amyotrophic Lateral Sclerosis |
| Q35357235 | Comparison of dendritic calcium transients in juvenile wild type and SOD1(G93A) mouse lumbar motoneurons |
| Q35957868 | Complex Inflammation mRNA-Related Response in ALS Is Region Dependent |
| Q34478634 | Concise review: Stem cell therapies for amyotrophic lateral sclerosis: recent advances and prospects for the future |
| Q37585552 | Defective cholesterol metabolism in amyotrophic lateral sclerosis |
| Q39177294 | Defining peripheral nervous system dysfunction in the SOD-1G93A transgenic rat model of amyotrophic lateral sclerosis |
| Q38761724 | Destination Brain: the Past, Present, and Future of Therapeutic Gene Delivery |
| Q26829668 | Development, maintenance and disruption of the blood-brain barrier |
| Q48141250 | Differential contribution of microglia and monocytes in neurodegenerative diseases. |
| Q48555685 | Disruption of calcitonin gene-related peptide signaling accelerates muscle denervation and dampens cytotoxic neuroinflammation in SOD1 mutant mice. |
| Q48707482 | Distributed corpus callosum involvement in amyotrophic lateral sclerosis: a deterministic tractography study using q-ball imaging. |
| Q33647461 | Epidermal growth factor receptor inhibitor ameliorates excessive astrogliosis and improves the regeneration microenvironment and functional recovery in adult rats following spinal cord injury |
| Q37694392 | Evaluating the levels of CSF and serum factors in ALS |
| Q36601006 | Expression of microRNAs in human post-mortem amyotrophic lateral sclerosis spinal cords provides insight into disease mechanisms |
| Q38985401 | Far beyond the motor neuron: the role of glial cells in amyotrophic lateral sclerosis |
| Q52606339 | Fibrinogen in neurological diseases: mechanisms, imaging and therapeutics. |
| Q34305789 | Functions of FUS/TLS from DNA repair to stress response: implications for ALS. |
| Q28392199 | HIV-1, methamphetamine and astrocytes at neuroinflammatory Crossroads |
| Q37427146 | Heavy metals in locus ceruleus and motor neurons in motor neuron disease |
| Q38816820 | Hematopoietic stem and progenitor cells as novel prognostic biomarkers of longevity in a murine model for amyotrophic lateral sclerosis |
| Q64115716 | Human Bone Marrow Endothelial Progenitor Cell Transplantation into Symptomatic ALS Mice Delays Disease Progression and Increases Motor Neuron Survival by Repairing Blood-Spinal Cord Barrier |
| Q39241549 | Human skin-derived precursor cells are poorly immunogenic and modulate the allogeneic immune response |
| Q35806256 | Humoral factors in ALS patients during disease progression. |
| Q48946777 | Imaging of brain TSPO expression in a mouse model of amyotrophic lateral sclerosis with (18)F-DPA-714 and micro-PET/CT. |
| Q41262976 | Immune responses in Parkinson's disease: interplay between central and peripheral immune systems |
| Q52726042 | Increased ROS Level in Spinal Cord of Wobbler Mice due to Nmnat2 Downregulation. |
| Q35849212 | Inflammation and neuronal death in the motor cortex of the wobbler mouse, an ALS animal model |
| Q44581205 | Innate and adaptive immune responses in neurodegeneration and repair. |
| Q35986943 | Interleukin-6 Deficiency Does Not Affect Motor Neuron Disease Caused by Superoxide Dismutase 1 Mutation |
| Q36679757 | Intraspinal stem cell transplantation for amyotrophic lateral sclerosis |
| Q36781712 | LPS-induced Murine Neuroinflammation Model: Main Features and Suitability for Pre-clinical Assessment of Nutraceuticals |
| Q35501802 | Linking RNA Dysfunction and Neurodegeneration in Amyotrophic Lateral Sclerosis |
| Q47352723 | Longitudinal structural changes in ALS: a three time-point imaging study of white and gray matter degeneration |
| Q36603298 | Macrophage-mediated inflammation and glial response in the skeletal muscle of a rat model of familial amyotrophic lateral sclerosis (ALS) |
| Q38958585 | Management and therapeutic perspectives in amyotrophic lateral sclerosis |
| Q27009559 | Microglia centered pathogenesis in ALS: insights in cell interconnectivity |
| Q33695687 | Microglia change from a reactive to an age-like phenotype with the time in culture |
| Q91813209 | Microglia priming by interleukin-6 signaling is enhanced in aged mice |
| Q36547001 | Microglial M1/M2 polarization and metabolic states |
| Q38728605 | Modulation of Microglial Activity by Rho-Kinase (ROCK) Inhibition as Therapeutic Strategy in Parkinson's Disease and Amyotrophic Lateral Sclerosis |
| Q30627110 | Myelin imaging in amyotrophic and primary lateral sclerosis |
| Q53413551 | NLRP3 inflammasome is expressed by astrocytes in the SOD1 mouse model of ALS and in human sporadic ALS patients. |
| Q48419091 | Neurodegeneration and NLRP3 inflammasome expression in the anterior thalamus of SOD1(G93A) ALS mice |
| Q89963614 | Neurodegenerative Susceptibility During Maternal Nutritional Programing: Are Central and Peripheral Innate Immune Training Relevant? |
| Q38983572 | Neuroimaging Endpoints in Amyotrophic Lateral Sclerosis |
| Q41824699 | Neuroinflammation as the proximate cause of signature pathogenic pattern progression in amyotrophic lateral sclerosis, AIDS, and multiple sclerosis |
| Q36942721 | Neurovascular unit in chronic pain |
| Q38701186 | Non-neuronal Cells in ALS: Role of Glial, Immune cells and Blood-CNS Barriers. |
| Q42077163 | P2Y(12) receptor on the verge of a neuroinflammatory breakdown |
| Q36311020 | PET imaging studies show enhanced expression of mGluR5 and inflammatory response during progressive degeneration in ALS mouse model expressing SOD1-G93A gene |
| Q38162323 | Paraoxonase 1 in neurological disorders. |
| Q37199221 | Pathways to neurodegeneration: mechanistic insights from GWAS in Alzheimer's disease, Parkinson's disease, and related disorders |
| Q47608879 | Plasma level of club-cell (CC-16) predicts outcome in amyotrophic lateral sclerosis. |
| Q35041471 | Plasma peptide biomarker discovery for amyotrophic lateral sclerosis by MALDI-TOF mass spectrometry profiling |
| Q47829271 | Potential Role of Humoral IL-6 Cytokine in Mediating Pro-Inflammatory Endothelial Cell Response in Amyotrophic Lateral Sclerosis. |
| Q40726584 | Reduced levels of alpha-1-antitrypsin in cerebrospinal fluid of amyotrophic lateral sclerosis patients: a novel approach for a potential treatment |
| Q34507926 | Scolopendra subspinipes mutilans attenuates neuroinflammation in symptomatic hSOD1(G93A) mice |
| Q64119028 | Spinal Cord Imaging in Amyotrophic Lateral Sclerosis: Historical Concepts-Novel Techniques |
| Q38397575 | Sulfhydryl-mediated redox signaling in inflammation: role in neurodegenerative diseases |
| Q26866679 | Sumoylation of critical proteins in amyotrophic lateral sclerosis: emerging pathways of pathogenesis |
| Q58136532 | THEME 11 THERAPEUTIC STRATEGIES |
| Q38674279 | Targeting specific cells in the brain with nanomedicines for CNS therapies |
| Q37141580 | The Immunoproteasome in oxidative stress, aging, and disease. |
| Q47257826 | The Neurovascular Unit Coming of Age: A Journey through Neurovascular Coupling in Health and Disease |
| Q48858477 | The Spatiotemporal Pattern of Degeneration in the Cerebellum of the Wobbler Mouse |
| Q48819479 | The effect of Se-deficient diet on gene expression of inflammatory cytokines in chicken brain |
| Q28391948 | The ubiquitin proteasome system in glia and its role in neurodegenerative diseases |
| Q37740938 | Treatment with penicillin G and hydrocortisone reduces ALS-associated symptoms: a case series of three patients |
| Q38202563 | Tumor necrosis factor receptor-associated periodic syndrome as a model linking autophagy and inflammation in protein aggregation diseases |
| Q36332951 | Type I Vs. Type II Cytokine Levels as a Function of SOD1 G93A Mouse Amyotrophic Lateral Sclerosis Disease Progression |
| Q33675140 | Ultra high-field (7tesla) magnetic resonance spectroscopy in Amyotrophic Lateral Sclerosis |
| Q34061536 | Voxel-based MRI intensitometry reveals extent of cerebral white matter pathology in amyotrophic lateral sclerosis |
| Q30234813 | What causes amyotrophic lateral sclerosis? |
| Q27007017 | What does imaging reveal about the pathology of amyotrophic lateral sclerosis? |
| Q58742056 | YKL40 in sporadic amyotrophic lateral sclerosis: cerebrospinal fluid levels as a prognosis marker of disease progression |
Search more.